CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to IPN.PA

Association of pembrolizumab + cabozantinib

Phase 2
Ipsen S.A. (IPN.PA)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
IPN.PAPhase 2

Association of pembrolizumab + cabozantinib Phase 2 Est. Readout (PEMBROCABOSARC)

Association of pembrolizumab + cabozantinib
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Soft Tissue Sarcoma Adult

View Full Landscape
Drug Information

Target Indication

Soft Tissue Sarcoma Adult

Clinical Trial

NCT05182164

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.